%0 Journal Article
%T Pharmaceutical intimacy: Managing female sexuality through Addyi
%A Jacinthe Flore
%J Sexualities
%@ 1461-7382
%D 2018
%R 10.1177/1363460717731933
%X In August 2015, the US Food and Drug Administration approved the production of Addyi (flibanserin), a pharmaceutical tablet for premenopausal women distressed by a lack of sexual desire. During clinical trials, reports from research participants revealed minimal efficacy: an estimated 0.8 increase in ¡®satisfying sexual events¡¯ per month. This article explores the emergence of Addyi as a case study of how this technique produces a particular subject of pharmaceutical knowledge. It examines the pharmaceutical tablet as a technique for the management of sexual appetite. I consider the significance of the act of pharmaceutical ingestion on the embodied subjectivity of the consumer and the chemical constitution of the human body
%K Addyi
%K desire
%K pharmaceuticals
%K sexuality
%K women
%U https://journals.sagepub.com/doi/full/10.1177/1363460717731933